Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restrictive Fluid Strategy in Postoperative Pancreatic Surgery
NCT03553394Terminated
- Sponsor
- Uppsala University
- Start
- Oct 2018
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Randomised, open-label trial of ringer's acetate in oliguria (2 arms), sponsored by Uppsala University. Primary endpoint: Urinary output at 2 hours. Started Oct 2018; status: terminated.
02
Drugs
ringer's acetate
03
Conditions
oliguria
Beyond the preview
Go deeper on NCT03553394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553394.